Development and validation of platelet-to-albumin ratio as a clinical predictor for diffuse large B-cell lymphoma

INTRODUCTION: Diffuse large B-cell lymphoma (DLBCL) is the most common subtypes of lymphoma. Clinical biomarkers are still required for DLBCL patients to identify high-risk patients. Therefore, we developed and validated the platelet-to-albumin (PTA) ratio as a predictor for DLBCL patients. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jinghan, Li, Linjie, Yu, Fang, Zhang, Junyu, Mao, Liping, Chen, Bocheng, Hu, Xuelian, Zhou, Hongmei, Xie, Wanzhuo, Tong, Hongyan, Jin, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285288/
https://www.ncbi.nlm.nih.gov/pubmed/37361573
http://dx.doi.org/10.3389/fonc.2023.1138284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285288/
https://www.ncbi.nlm.nih.gov/pubmed/37361573
http://dx.doi.org/10.3389/fonc.2023.1138284

Ejemplares similares